nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A5—Thalidomide—leprosy	0.172	0.289	CbGbCtD
Paliperidone—CYP3A5—Rifampicin—leprosy	0.167	0.28	CbGbCtD
Paliperidone—CYP3A5—Dapsone—leprosy	0.138	0.231	CbGbCtD
Paliperidone—CYP3A4—Rifampicin—leprosy	0.065	0.109	CbGbCtD
Paliperidone—CYP3A4—Dapsone—leprosy	0.0536	0.0902	CbGbCtD
Paliperidone—HTR1B—trigeminal nerve—leprosy	0.0155	0.103	CbGeAlD
Paliperidone—HTR1D—trigeminal nerve—leprosy	0.015	0.0993	CbGeAlD
Paliperidone—HRH1—nose—leprosy	0.0114	0.0753	CbGeAlD
Paliperidone—HTR1B—cranial nerve—leprosy	0.0111	0.0731	CbGeAlD
Paliperidone—HTR1D—cranial nerve—leprosy	0.0107	0.0708	CbGeAlD
Paliperidone—Teratogenicity—Thalidomide—leprosy	0.00952	0.0375	CcSEcCtD
Paliperidone—HTR2A—trigeminal nerve—leprosy	0.00746	0.0493	CbGeAlD
Paliperidone—DRD1—nerve—leprosy	0.007	0.0462	CbGeAlD
Paliperidone—HTR2A—cranial nerve—leprosy	0.00532	0.0352	CbGeAlD
Paliperidone—Rales—Thalidomide—leprosy	0.00486	0.0192	CcSEcCtD
Paliperidone—HTR2A—hindlimb—leprosy	0.00448	0.0296	CbGeAlD
Paliperidone—HTR1B—blood vessel—leprosy	0.00445	0.0294	CbGeAlD
Paliperidone—Parkinsonism—Thalidomide—leprosy	0.00439	0.0173	CcSEcCtD
Paliperidone—Altered state of consciousness—Thalidomide—leprosy	0.00432	0.017	CcSEcCtD
Paliperidone—HTR1D—blood vessel—leprosy	0.00431	0.0285	CbGeAlD
Paliperidone—Grand mal convulsion—Thalidomide—leprosy	0.00419	0.0165	CcSEcCtD
Paliperidone—DRD2—nerve—leprosy	0.00413	0.0273	CbGeAlD
Paliperidone—Cerebral ischaemia—Thalidomide—leprosy	0.00413	0.0163	CcSEcCtD
Paliperidone—ADRA2A—peripheral nervous system—leprosy	0.00411	0.0272	CbGeAlD
Paliperidone—White blood cell count decreased—Thalidomide—leprosy	0.00401	0.0158	CcSEcCtD
Paliperidone—Embolism venous—Thalidomide—leprosy	0.00395	0.0156	CcSEcCtD
Paliperidone—Transient ischaemic attack—Thalidomide—leprosy	0.00395	0.0156	CcSEcCtD
Paliperidone—Nuchal rigidity—Thalidomide—leprosy	0.00385	0.0151	CcSEcCtD
Paliperidone—HTR2A—appendage—leprosy	0.00385	0.0254	CbGeAlD
Paliperidone—Venous thrombosis—Thalidomide—leprosy	0.0037	0.0146	CcSEcCtD
Paliperidone—Sexual dysfunction—Thalidomide—leprosy	0.00356	0.014	CcSEcCtD
Paliperidone—HTR2A—peripheral nervous system—leprosy	0.0035	0.0231	CbGeAlD
Paliperidone—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00343	0.0135	CcSEcCtD
Paliperidone—Toothache—Thalidomide—leprosy	0.00328	0.0129	CcSEcCtD
Paliperidone—Deep vein thrombosis—Thalidomide—leprosy	0.00328	0.0129	CcSEcCtD
Paliperidone—DRD4—testis—leprosy	0.00318	0.0211	CbGeAlD
Paliperidone—Galactorrhoea—Thalidomide—leprosy	0.00308	0.0121	CcSEcCtD
Paliperidone—Intestinal obstruction—Thalidomide—leprosy	0.00293	0.0115	CcSEcCtD
Paliperidone—Menstrual disorder—Thalidomide—leprosy	0.00293	0.0115	CcSEcCtD
Paliperidone—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00293	0.0115	CcSEcCtD
Paliperidone—HTR2A—nerve—leprosy	0.00273	0.018	CbGeAlD
Paliperidone—Stupor—Thalidomide—leprosy	0.00267	0.0105	CcSEcCtD
Paliperidone—Nasopharyngitis—Dapsone—leprosy	0.00253	0.00996	CcSEcCtD
Paliperidone—Muscular weakness—Dapsone—leprosy	0.0025	0.00983	CcSEcCtD
Paliperidone—Influenza—Dapsone—leprosy	0.00245	0.00963	CcSEcCtD
Paliperidone—Endocrine disorder—Thalidomide—leprosy	0.00241	0.00948	CcSEcCtD
Paliperidone—Pancreatitis—Dapsone—leprosy	0.0024	0.00944	CcSEcCtD
Paliperidone—Acne—Thalidomide—leprosy	0.00237	0.00934	CcSEcCtD
Paliperidone—HTR1D—eye—leprosy	0.00229	0.0152	CbGeAlD
Paliperidone—Amenorrhoea—Thalidomide—leprosy	0.00227	0.00894	CcSEcCtD
Paliperidone—Musculoskeletal stiffness—Thalidomide—leprosy	0.00222	0.00876	CcSEcCtD
Paliperidone—Viral infection—Thalidomide—leprosy	0.00221	0.0087	CcSEcCtD
Paliperidone—Skin discolouration—Thalidomide—leprosy	0.00221	0.0087	CcSEcCtD
Paliperidone—DRD3—nervous system—leprosy	0.0022	0.0145	CbGeAlD
Paliperidone—Cellulitis—Thalidomide—leprosy	0.00219	0.00864	CcSEcCtD
Paliperidone—HTR2A—blood vessel—leprosy	0.00214	0.0141	CbGeAlD
Paliperidone—Dyskinesia—Thalidomide—leprosy	0.00212	0.00836	CcSEcCtD
Paliperidone—Atrioventricular block—Thalidomide—leprosy	0.00206	0.0081	CcSEcCtD
Paliperidone—Sinusitis—Dapsone—leprosy	0.00205	0.00806	CcSEcCtD
Paliperidone—Gait disturbance—Thalidomide—leprosy	0.00204	0.00805	CcSEcCtD
Paliperidone—Coordination abnormal—Thalidomide—leprosy	0.00203	0.008	CcSEcCtD
Paliperidone—Neck pain—Thalidomide—leprosy	0.00202	0.00795	CcSEcCtD
Paliperidone—Pulmonary embolism—Thalidomide—leprosy	0.002	0.00786	CcSEcCtD
Paliperidone—Depressed level of consciousness—Thalidomide—leprosy	0.00193	0.00759	CcSEcCtD
Paliperidone—Dry eye—Thalidomide—leprosy	0.00184	0.00726	CcSEcCtD
Paliperidone—Tinnitus—Dapsone—leprosy	0.00182	0.00719	CcSEcCtD
Paliperidone—Gynaecomastia—Thalidomide—leprosy	0.00179	0.00703	CcSEcCtD
Paliperidone—Hypertonia—Thalidomide—leprosy	0.00175	0.00689	CcSEcCtD
Paliperidone—Hyperkinesia—Thalidomide—leprosy	0.00174	0.00685	CcSEcCtD
Paliperidone—DRD2—eye—leprosy	0.00173	0.0114	CbGeAlD
Paliperidone—Erythema—Dapsone—leprosy	0.0017	0.00671	CcSEcCtD
Paliperidone—ADRA1B—nervous system—leprosy	0.00169	0.0112	CbGeAlD
Paliperidone—Diabetes mellitus—Thalidomide—leprosy	0.00166	0.00656	CcSEcCtD
Paliperidone—Gastroenteritis—Thalidomide—leprosy	0.00163	0.00644	CcSEcCtD
Paliperidone—Eczema—Thalidomide—leprosy	0.00161	0.00635	CcSEcCtD
Paliperidone—Vision blurred—Dapsone—leprosy	0.00161	0.00632	CcSEcCtD
Paliperidone—DRD1—nervous system—leprosy	0.00157	0.0104	CbGeAlD
Paliperidone—Libido decreased—Thalidomide—leprosy	0.00156	0.00615	CcSEcCtD
Paliperidone—Increased appetite—Thalidomide—leprosy	0.00154	0.00607	CcSEcCtD
Paliperidone—Vertigo—Dapsone—leprosy	0.00153	0.00603	CcSEcCtD
Paliperidone—Atrial fibrillation—Thalidomide—leprosy	0.00153	0.00602	CcSEcCtD
Paliperidone—Cough—Dapsone—leprosy	0.00149	0.00586	CcSEcCtD
Paliperidone—Hypoglycaemia—Thalidomide—leprosy	0.00148	0.00585	CcSEcCtD
Paliperidone—Cerebrovascular accident—Thalidomide—leprosy	0.00148	0.00582	CcSEcCtD
Paliperidone—Lethargy—Thalidomide—leprosy	0.00148	0.00582	CcSEcCtD
Paliperidone—Pain in extremity—Thalidomide—leprosy	0.00145	0.0057	CcSEcCtD
Paliperidone—Osteoarthritis—Thalidomide—leprosy	0.00145	0.0057	CcSEcCtD
Paliperidone—Disturbance in sexual arousal—Thalidomide—leprosy	0.00144	0.00566	CcSEcCtD
Paliperidone—Face oedema—Thalidomide—leprosy	0.0014	0.00551	CcSEcCtD
Paliperidone—Cardiac arrest—Thalidomide—leprosy	0.00138	0.00542	CcSEcCtD
Paliperidone—HRH1—eye—leprosy	0.00136	0.00902	CbGeAlD
Paliperidone—Tachycardia—Dapsone—leprosy	0.00136	0.00535	CcSEcCtD
Paliperidone—Dry skin—Thalidomide—leprosy	0.00133	0.00523	CcSEcCtD
Paliperidone—Orthostatic hypotension—Thalidomide—leprosy	0.00132	0.00521	CcSEcCtD
Paliperidone—Breast disorder—Thalidomide—leprosy	0.00131	0.00515	CcSEcCtD
Paliperidone—Aspartate aminotransferase increased—Thalidomide—leprosy	0.0013	0.00514	CcSEcCtD
Paliperidone—Muscular weakness—Thalidomide—leprosy	0.00128	0.00503	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Thalidomide—leprosy	0.00128	0.00503	CcSEcCtD
Paliperidone—HTR1B—nervous system—leprosy	0.00127	0.00843	CbGeAlD
Paliperidone—Insomnia—Dapsone—leprosy	0.00126	0.00495	CcSEcCtD
Paliperidone—Dysphagia—Thalidomide—leprosy	0.00125	0.00493	CcSEcCtD
Paliperidone—Influenza—Thalidomide—leprosy	0.00125	0.00493	CcSEcCtD
Paliperidone—HTR1D—nervous system—leprosy	0.00123	0.00816	CbGeAlD
Paliperidone—Pancreatitis—Thalidomide—leprosy	0.00123	0.00483	CcSEcCtD
Paliperidone—HTR2C—nervous system—leprosy	0.00122	0.00808	CbGeAlD
Paliperidone—Bronchitis—Thalidomide—leprosy	0.0012	0.00474	CcSEcCtD
Paliperidone—Neutropenia—Thalidomide—leprosy	0.00117	0.00461	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Thalidomide—leprosy	0.00116	0.00458	CcSEcCtD
Paliperidone—Pollakiuria—Thalidomide—leprosy	0.00116	0.00455	CcSEcCtD
Paliperidone—Erectile dysfunction—Thalidomide—leprosy	0.00115	0.00454	CcSEcCtD
Paliperidone—HTR2A—eye—leprosy	0.00114	0.00753	CbGeAlD
Paliperidone—Weight increased—Thalidomide—leprosy	0.00114	0.00449	CcSEcCtD
Paliperidone—Gastrointestinal pain—Dapsone—leprosy	0.00114	0.00448	CcSEcCtD
Paliperidone—Weight decreased—Thalidomide—leprosy	0.00113	0.00446	CcSEcCtD
Paliperidone—Hyperglycaemia—Thalidomide—leprosy	0.00113	0.00445	CcSEcCtD
Paliperidone—Pneumonia—Thalidomide—leprosy	0.00112	0.00442	CcSEcCtD
Paliperidone—Infestation NOS—Thalidomide—leprosy	0.00112	0.0044	CcSEcCtD
Paliperidone—Infestation—Thalidomide—leprosy	0.00112	0.0044	CcSEcCtD
Paliperidone—Depression—Thalidomide—leprosy	0.00111	0.00438	CcSEcCtD
Paliperidone—ADRA2C—tendon—leprosy	0.00111	0.00735	CbGeAlD
Paliperidone—Abdominal pain—Dapsone—leprosy	0.0011	0.00433	CcSEcCtD
Paliperidone—Body temperature increased—Dapsone—leprosy	0.0011	0.00433	CcSEcCtD
Paliperidone—Conjunctivitis—Thalidomide—leprosy	0.00108	0.00427	CcSEcCtD
Paliperidone—Epistaxis—Thalidomide—leprosy	0.00105	0.00415	CcSEcCtD
Paliperidone—Sinusitis—Thalidomide—leprosy	0.00105	0.00412	CcSEcCtD
Paliperidone—Agranulocytosis—Thalidomide—leprosy	0.00104	0.0041	CcSEcCtD
Paliperidone—HTR1A—nervous system—leprosy	0.00103	0.0068	CbGeAlD
Paliperidone—Bradycardia—Thalidomide—leprosy	0.00102	0.00402	CcSEcCtD
Paliperidone—Rhinitis—Thalidomide—leprosy	0.001	0.00396	CcSEcCtD
Paliperidone—Hypoaesthesia—Thalidomide—leprosy	0.000997	0.00393	CcSEcCtD
Paliperidone—Urinary tract disorder—Thalidomide—leprosy	0.000989	0.0039	CcSEcCtD
Paliperidone—Oedema peripheral—Thalidomide—leprosy	0.000987	0.00389	CcSEcCtD
Paliperidone—Urethral disorder—Thalidomide—leprosy	0.000982	0.00387	CcSEcCtD
Paliperidone—ADRA1A—nervous system—leprosy	0.000948	0.00627	CbGeAlD
Paliperidone—DRD2—testis—leprosy	0.000947	0.00626	CbGeAlD
Paliperidone—Eye disorder—Thalidomide—leprosy	0.000936	0.00369	CcSEcCtD
Paliperidone—Tinnitus—Thalidomide—leprosy	0.000934	0.00368	CcSEcCtD
Paliperidone—Cardiac disorder—Thalidomide—leprosy	0.00093	0.00366	CcSEcCtD
Paliperidone—DRD2—nervous system—leprosy	0.00093	0.00614	CbGeAlD
Paliperidone—ADRA2C—testis—leprosy	0.000921	0.00609	CbGeAlD
Paliperidone—Angiopathy—Thalidomide—leprosy	0.000909	0.00358	CcSEcCtD
Paliperidone—Immune system disorder—Thalidomide—leprosy	0.000905	0.00356	CcSEcCtD
Paliperidone—ADRA2C—nervous system—leprosy	0.000904	0.00597	CbGeAlD
Paliperidone—HRH1—tendon—leprosy	0.000903	0.00597	CbGeAlD
Paliperidone—Mediastinal disorder—Thalidomide—leprosy	0.000903	0.00356	CcSEcCtD
Paliperidone—Chills—Thalidomide—leprosy	0.000899	0.00354	CcSEcCtD
Paliperidone—ADRA2A—tendon—leprosy	0.000887	0.00586	CbGeAlD
Paliperidone—Alopecia—Thalidomide—leprosy	0.000885	0.00349	CcSEcCtD
Paliperidone—Vomiting—Dapsone—leprosy	0.000884	0.00348	CcSEcCtD
Paliperidone—Mental disorder—Thalidomide—leprosy	0.000878	0.00346	CcSEcCtD
Paliperidone—Malnutrition—Thalidomide—leprosy	0.000872	0.00344	CcSEcCtD
Paliperidone—Headache—Dapsone—leprosy	0.000871	0.00343	CcSEcCtD
Paliperidone—Flatulence—Thalidomide—leprosy	0.000859	0.00339	CcSEcCtD
Paliperidone—Tension—Thalidomide—leprosy	0.000856	0.00337	CcSEcCtD
Paliperidone—Dysgeusia—Thalidomide—leprosy	0.000854	0.00336	CcSEcCtD
Paliperidone—Nervousness—Thalidomide—leprosy	0.000847	0.00334	CcSEcCtD
Paliperidone—Back pain—Thalidomide—leprosy	0.000844	0.00332	CcSEcCtD
Paliperidone—Muscle spasms—Thalidomide—leprosy	0.000839	0.0033	CcSEcCtD
Paliperidone—Nausea—Dapsone—leprosy	0.000826	0.00325	CcSEcCtD
Paliperidone—Vision blurred—Thalidomide—leprosy	0.000822	0.00324	CcSEcCtD
Paliperidone—Tremor—Thalidomide—leprosy	0.000817	0.00322	CcSEcCtD
Paliperidone—Ill-defined disorder—Thalidomide—leprosy	0.000809	0.00319	CcSEcCtD
Paliperidone—Anaemia—Thalidomide—leprosy	0.000806	0.00318	CcSEcCtD
Paliperidone—Agitation—Thalidomide—leprosy	0.000801	0.00316	CcSEcCtD
Paliperidone—Angioedema—Thalidomide—leprosy	0.000797	0.00314	CcSEcCtD
Paliperidone—Malaise—Thalidomide—leprosy	0.000786	0.0031	CcSEcCtD
Paliperidone—Vertigo—Thalidomide—leprosy	0.000784	0.00309	CcSEcCtD
Paliperidone—Syncope—Thalidomide—leprosy	0.000782	0.00308	CcSEcCtD
Paliperidone—Leukopenia—Thalidomide—leprosy	0.000781	0.00307	CcSEcCtD
Paliperidone—Palpitations—Thalidomide—leprosy	0.000771	0.00304	CcSEcCtD
Paliperidone—Loss of consciousness—Thalidomide—leprosy	0.000767	0.00302	CcSEcCtD
Paliperidone—Cough—Thalidomide—leprosy	0.000761	0.003	CcSEcCtD
Paliperidone—Convulsion—Thalidomide—leprosy	0.000756	0.00298	CcSEcCtD
Paliperidone—HTR2A—tendon—leprosy	0.000754	0.00499	CbGeAlD
Paliperidone—Hypertension—Thalidomide—leprosy	0.000753	0.00297	CcSEcCtD
Paliperidone—HRH1—testis—leprosy	0.000748	0.00494	CbGeAlD
Paliperidone—Chest pain—Thalidomide—leprosy	0.000743	0.00292	CcSEcCtD
Paliperidone—Myalgia—Thalidomide—leprosy	0.000743	0.00292	CcSEcCtD
Paliperidone—Arthralgia—Thalidomide—leprosy	0.000743	0.00292	CcSEcCtD
Paliperidone—Anxiety—Thalidomide—leprosy	0.00074	0.00291	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000737	0.0029	CcSEcCtD
Paliperidone—ADRA2A—testis—leprosy	0.000735	0.00486	CbGeAlD
Paliperidone—HRH1—nervous system—leprosy	0.000734	0.00485	CbGeAlD
Paliperidone—Discomfort—Thalidomide—leprosy	0.000734	0.00289	CcSEcCtD
Paliperidone—Dry mouth—Thalidomide—leprosy	0.000726	0.00286	CcSEcCtD
Paliperidone—ADRA2A—nervous system—leprosy	0.000721	0.00477	CbGeAlD
Paliperidone—Confusional state—Thalidomide—leprosy	0.000718	0.00283	CcSEcCtD
Paliperidone—Oedema—Thalidomide—leprosy	0.000712	0.0028	CcSEcCtD
Paliperidone—Infection—Thalidomide—leprosy	0.000707	0.00279	CcSEcCtD
Paliperidone—Shock—Thalidomide—leprosy	0.0007	0.00276	CcSEcCtD
Paliperidone—Nervous system disorder—Thalidomide—leprosy	0.000698	0.00275	CcSEcCtD
Paliperidone—Thrombocytopenia—Thalidomide—leprosy	0.000697	0.00275	CcSEcCtD
Paliperidone—Tachycardia—Thalidomide—leprosy	0.000695	0.00274	CcSEcCtD
Paliperidone—Skin disorder—Thalidomide—leprosy	0.000691	0.00272	CcSEcCtD
Paliperidone—Anorexia—Thalidomide—leprosy	0.000678	0.00267	CcSEcCtD
Paliperidone—Hypotension—Thalidomide—leprosy	0.000665	0.00262	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000648	0.00255	CcSEcCtD
Paliperidone—Insomnia—Thalidomide—leprosy	0.000644	0.00254	CcSEcCtD
Paliperidone—Paraesthesia—Thalidomide—leprosy	0.000639	0.00252	CcSEcCtD
Paliperidone—Dyspnoea—Thalidomide—leprosy	0.000635	0.0025	CcSEcCtD
Paliperidone—Somnolence—Thalidomide—leprosy	0.000633	0.00249	CcSEcCtD
Paliperidone—Dyspepsia—Thalidomide—leprosy	0.000627	0.00247	CcSEcCtD
Paliperidone—HTR2A—testis—leprosy	0.000625	0.00413	CbGeAlD
Paliperidone—Decreased appetite—Thalidomide—leprosy	0.000619	0.00244	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Thalidomide—leprosy	0.000615	0.00242	CcSEcCtD
Paliperidone—Fatigue—Thalidomide—leprosy	0.000614	0.00242	CcSEcCtD
Paliperidone—HTR2A—nervous system—leprosy	0.000613	0.00405	CbGeAlD
Paliperidone—Constipation—Thalidomide—leprosy	0.000609	0.0024	CcSEcCtD
Paliperidone—Pain—Thalidomide—leprosy	0.000609	0.0024	CcSEcCtD
Paliperidone—Feeling abnormal—Thalidomide—leprosy	0.000587	0.00231	CcSEcCtD
Paliperidone—Gastrointestinal pain—Thalidomide—leprosy	0.000582	0.00229	CcSEcCtD
Paliperidone—CYP2D6—testis—leprosy	0.000569	0.00376	CbGeAlD
Paliperidone—CYP3A4—nervous system—leprosy	0.000568	0.00375	CbGeAlD
Paliperidone—Urticaria—Thalidomide—leprosy	0.000565	0.00223	CcSEcCtD
Paliperidone—Abdominal pain—Thalidomide—leprosy	0.000563	0.00222	CcSEcCtD
Paliperidone—Body temperature increased—Thalidomide—leprosy	0.000563	0.00222	CcSEcCtD
Paliperidone—CYP2D6—nervous system—leprosy	0.000559	0.00369	CbGeAlD
Paliperidone—Hypersensitivity—Thalidomide—leprosy	0.000524	0.00207	CcSEcCtD
Paliperidone—Asthenia—Thalidomide—leprosy	0.000511	0.00201	CcSEcCtD
Paliperidone—Pruritus—Thalidomide—leprosy	0.000504	0.00198	CcSEcCtD
Paliperidone—Diarrhoea—Thalidomide—leprosy	0.000487	0.00192	CcSEcCtD
Paliperidone—Dizziness—Thalidomide—leprosy	0.000471	0.00185	CcSEcCtD
Paliperidone—Vomiting—Thalidomide—leprosy	0.000453	0.00178	CcSEcCtD
Paliperidone—Rash—Thalidomide—leprosy	0.000449	0.00177	CcSEcCtD
Paliperidone—Dermatitis—Thalidomide—leprosy	0.000448	0.00177	CcSEcCtD
Paliperidone—Headache—Thalidomide—leprosy	0.000446	0.00176	CcSEcCtD
Paliperidone—Nausea—Thalidomide—leprosy	0.000423	0.00167	CcSEcCtD
